← Open Payments lookup

NAMITA PURAN: Open Payments

NPI 1619591245 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$453 in 18 payments from 10 companies in 2025. Trend: 2023 $47 · 2024 $308 · 2025 $453

Food & beverage: $343Education: $110
CompanyPaymentsAmount
Merck Sharp & Dohme LLC5$129
Lilly USA, LLC2$116
Novartis Pharmaceuticals Corporation2$44
Caris MPI, Inc.2$38
Gilead Sciences, Inc.2$25
Stemline Therapeutics Inc.1$25
Incyte Corporation1$22
Daiichi Sankyo Inc.1$20
TerSera Therapeutics LLC1$18
Janssen Biotech, Inc.1$17

Products named: KEYTRUDA, MI CANCER SEEK, VERZENIO, Orserdu, SCEMBLIX, ZYNYZ, Enhertu, KISQALI.

Industry payments across DC — which companies pay providers there.